2020
Elective Colectomy in a Patient with Active Ulcerative Colitis and Metastatic Melanoma Enabling Successful Treatment with Immune Checkpoint Inhibitors.
Perdigoto AL, Tran T, Patel N, Clark P, Patell K, Stamatouli AM, Reddy V, Clune J, Herold KC, Robert ME, Kluger HM. Elective Colectomy in a Patient with Active Ulcerative Colitis and Metastatic Melanoma Enabling Successful Treatment with Immune Checkpoint Inhibitors. Clinical Oncology Case Reports 2020, 3 PMID: 33778814, PMCID: PMC7993656.Peer-Reviewed Original ResearchCheckpoint inhibitor therapyElective colectomyUlcerative colitisInhibitor therapyMetastatic melanomaImmune-related adverse eventsExcellent tumor responseImmune checkpoint inhibitorsSevere ulcerative colitisActive ulcerative colitisCheckpoint inhibitor immunotherapyCheckpoint inhibitor treatmentInflammatory bowel diseaseEffective treatment optionBenefits of treatmentImmune system activationTumor cell destructionCheckpoint inhibitorsAdvanced malignanciesAdverse eventsSelect patientsBowel diseaseAutoimmune diseasesTreatment optionsTumor response
1997
Characterization of afferent mechanisms in ileoanal pouches.
Bernstein C, Rollandelli R, Niazi N, Robert M, Hirsh T, Munakata J, Mayer E. Characterization of afferent mechanisms in ileoanal pouches. The American Journal Of Gastroenterology 1997, 92: 103-8. PMID: 8995947.Peer-Reviewed Original ResearchConceptsIleoanal pouchPouch complianceProximal ileumActive ulcerative colitisAnal sphincter functionAfferent nerve functionBalloon distentionIntrapouch pressureS3 dermatomesNerve functionPouch functionSphincter functionAfferent mechanismsUlcerative colitisAfferent innervationClinical featuresClinical presentationColorectal inflammationReferral patternsReflex functionReflex regulationAfferent pathwaysDistention pressuresLower volume thresholdRamp distention